Ustekinumab for Psoriasis and Psoriatic Arthritis

被引：18
|
作者：
Gottlieb, Alice Bendix [1 ]
Goldminz, Ari Michael [1 ]
机构：
[1] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Dermatol, Boston, MA 02111 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷
关键词：
USTEKINUMAB; PSORIASIS; PSORIATIC ARTHRITIS; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RANDOMIZED-TRIAL; TNF INHIBITION; SAFETY; EFFICACY; ASSOCIATION;
D O I：
10.3899/jrheum.120253
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ustekinumab, which is approved for the treatment of moderate to severe psoriasis, has been shown in phase II clinical trials to be efficacious in controlling the signs and symptoms of psoriatic arthritis. Ustekinumab appears to be well tolerated, but its longterm safety profile is not yet known. (J Rheumatol 2012;39 Suppl 89:86-9; doi:10.3899/jrheum.120253)
引用
收藏
页码：86 / 89
页数：4
相关论文
共 50 条
  • [1] Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
    Savage L.J.
    Wittmann M.
    McGonagle D.
    Helliwell P.S.
    [J]. Rheumatology and Therapy, 2015, 2 (1) : 1 - 16
  • [2] Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab
    Carija, Antoanela
    Ivic, Ivo
    Marasovic-Krstulovic, Daniela
    Puizina-Ivic, Neira
    [J]. RHEUMATOLOGY, 2015, 54 (11) : 2114 - 2116
  • [3] Ustekinumab: A Review in the Treatment of Plaque Psoriasis and Psoriatic Arthritis
    Zaghi, Daniel
    Krueger, Gerald G.
    Duffin, Kristina Callis
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (02) : 160 - 167
  • [4] Pregnancy outcomes in women with psoriasis and psoriatic arthritis exposed to ustekinumab
    Naureckas, Saule
    Slater, Jennifer
    Gearhart, Natalie
    Ramachandran, Paraneedharan
    Nissinen, Riikka
    Hopkins, Lori
    Geldhof, Anja
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB264 - AB264
  • [5] Ustekinumab for psoriatic arthritis
    Cuchacovich, Raquel S.
    Espinoza, Luis R.
    [J]. LANCET, 2009, 373 (9664): : 605 - 606
  • [6] Ustekinumab for Psoriasis and Psoriatic Arthritis (vol 89, pg 86, 2012)
    Gottlieb, A. B.
    Goldminz, A. M.
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (09) : 1908 - 1908
  • [7] Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review
    Thibodaux, Ross J.
    Triche, Mallory W.
    Espinoza, Luis R.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (07) : 821 - 827
  • [8] Ustekinumab, Apremilast, TNFi and the Risk for Hospitalized Infection in Patients with Psoriasis and Psoriatic Arthritis
    Xie, Fenglong
    Chen, Lang
    Yun, Huifeng
    Beukelman, Timothy
    Curtis, Jeffrey
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Ustekinumab and the Comparative Risk for Acute Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis
    Xie, Fenglong
    Chen, Lang
    Yun, Huifeng
    Curtis, Jeffrey R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Ustekinumab for the treatment of psoriatic arthritis
    Chandler, David John
    Bewley, Anthony
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (02) : 111 - 121
12345